Published in Elder Law Weekly, March 23rd, 2005
According to a study from the United States, "The authors report a patient with Alzheimer disease without encephalitis who was immunized with AN-1792 (an adjuvanted formulation of A-beta-42). There were no amyloid plaques in the frontal cortex and abundant A-beta-immunoreactive macrophages, but tangles and amyloid angiopathy were present. The white matter appeared normal and minimal lymphocytic infiltration in the leptomeninges was observed."
"This case illustrates the effects...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.